Search for: "May v. Amgen, Inc." Results 61 - 80 of 298
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
BPCIA Notice of Commercial Marketing Requirement Privately Enforceable Via Declaratory Relief Claim
9 Aug 2016, 7:50 am by Docket Navigator
" Amgen Inc. et al v. [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Wednesday round-up
26 Apr 2017, 4:17 am by Edith Roberts
The first is Amgen Inc. v. [read post]
SCOTUSblog - http://www.scotusblog.com/
“Exceptional Case” Rule does Not apply to Doctrine of Equivalents
3 Sep 2019, 8:24 am by Dennis Crouch
by Dennis Crouch Amgen v. [read post]
Patently-O - http://patentlyo.com/patent
Industry Sponsors, Investigators and Their Obligations in Clinical Trials
28 Jun 2007, 1:03 pm
Amgen, Inc. by the Sixth Circuit in March 2006. [read post]
Law and Other Things - http://lawandotherthings.blogspot.com/
Supreme Court Rules for Biosimilar Applicants under the BPCIA
15 Jun 2017, 10:00 pm
Post By Blog Staff On June 12, 2017, the Supreme Court released a decision in Sandoz Inc. v. [read post]
Filewrapper.com - http://www.filewrapper.com/
Defendant's belief its ads were effective is evidence of injury
24 Jul 2023, 6:55 am by Rebecca Tushnet
Sandoz Inc. v. [read post]
43(B)log - http://tushnet.blogspot.com/
Amgen Inc. v. Connecticut Retirement Plans and Trust Funds: Does Supreme Court Put “Cart Before The Horse” To Satisfy Predominance Requirement?
28 Feb 2013, 8:13 am
While it is clear that Amgen is an important decision for securities fraud cases, we expect it to impact future class actions in general. [read post]
Class Action Blog - http://www.cfjblaw.com/classactionblog/blog.aspx
The Long Lashes of the Law: The Federal Circuit Rejects Nation-wide Application of An Injunction Based on California Unfair Competition Statutes
13 Jan 2014, 2:33 pm
By:David Gabor On December 30, 2013, the Federal Court of Appeals, in Allergan, Inc. v. [read post]
IP Law Blog - http://www.theiplawblog.com/
Momenta Pharmaceuticals: The Hatch-Waxman “Safe Harbor” Widens to Include Post-FDA Approval Activity*
7 Aug 2012, 7:27 am by Eric Guttag
Related posts: Divisional of Divisional Reaches Safe Harbor of 35 U.S.C § 121Some may recall my “dissertation” on the case of Amgen Inc. v. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Guest Post: Ann Lipton on Amgen
13 Mar 2013, 5:23 am by Rebecca Tushnet
  In Amgen Inc. v. [read post]
43(B)log - http://tushnet.blogspot.com/
Functional Claim “Raises the Bar for Enablement”
16 Feb 2021, 7:57 pm by Dennis Crouch
by Dennis Crouch Amgen v. [read post]
Patently-O - http://patentlyo.com/patent
Warnings and Punitive Damages
24 Feb 2012, 5:52 am by Bexis
Amgen Inc., 2012 WL 517446 (W.D. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Biosimilars and Temporary Restraining Orders
6 Jul 2020, 8:49 am by Dennis Crouch
[Sandoz Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
Data Engine v. Google. Google wins on preamble issue. Nose of wax.
26 Aug 2021, 1:05 pm by Lawrence B. Ebert
Cir. 2001) (citation omitted); Amgen Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Argument analysis: The Supreme Court struggles with the ACA’s patent provisions
28 Apr 2017, 6:01 am by John Duffy
Amgen and Amgen v. [read post]
SCOTUSblog - http://www.scotusblog.com/
Argument preview: The ACA returns to the Supreme Court (this time disguised as a hugely complex patent case)
24 Apr 2017, 11:12 am by John Duffy
Amgen and Amgen v. [read post]
SCOTUSblog - http://www.scotusblog.com/
U.S. Supreme Court Allows Early Notice For Biosimilars
15 Jun 2017, 2:09 pm by Eric Caligiuri
In SANDOZ INC. v. [read post]
IP Law Blog - http://www.theiplawblog.com/
U.S. Supreme Court Allows Early Notice For Biosimilars
15 Jun 2017, 2:09 pm by Eric Caligiuri
In SANDOZ INC. v. [read post]
IP Law Blog - http://www.theiplawblog.com/
Opening a Closed Markush Group
8 Jan 2020, 11:16 am by Dennis Crouch
” Intervet Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
Gov’t Brief on Full Scope Enablement: Specification Must Enable the Entire Genus
22 Sep 2022, 4:31 am by Dennis Crouch
Gov’t CVSG Brief in Amgen Inc. v. [read post]
Patently-O - https://patentlyo.com